Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal CBD:THC Ratio in Cannabis Users
NCT05170217Completed
- Sponsor
- King's College London
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cannabidiol in cannabis use disorder (CUD) (4 arms), sponsored by King's College London. Primary endpoint: Hopkins Verbal Learning Task. Started Nov 2017; status: completed.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT05170217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05170217.